Picasso Kapital
Picasso Kapital AS is a strategic investment firm based in Harstad, Norway, focused on long-term investments. Historically, the firm specialized in the healthcare sector, actively seeking opportunities to enhance its portfolio. Through its investment strategies, Picasso Kapital aimed to generate sustainable growth and value over time.
1 past transactions
Lytix Biopharma
Venture Round in 2009
Lytix Biopharma is a clinical-stage biotechnology company focused on cancer immunotherapies that aim to activate the patient’s immune system to fight cancer. Its pipeline includes LTX-315, an oncolytic peptide that reshapes the tumor microenvironment by releasing potent immune stimulants and tumor antigens, and LTX-401, with programs in development. The company also provides research and development services. Founded in 2003 and based in Oslo with operations in Tromsø, it conducts activities in Norway and the United States, with a majority of revenue sourced from the United States.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.